Dupont Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,221
| Closed | -$102K | – | 1469 |
|
|
2022
Q3 | $102K | Buy |
+24,221
| New | +$102K | 0.01% | 1028 |
|
|
2021
Q4 | – | Sell |
-21,153
| Closed | -$226K | – | 1766 |
|
|
2021
Q3 | $226K | Sell |
21,153
-2,990
| -12% | -$31.9K | 0.01% | 1200 |
|
|
2021
Q2 | $375K | Hold |
24,143
| – | – | 0.01% | 1119 |
|
|
2021
Q1 | $391K | Sell |
24,143
-4,952
| -17% | -$80.2K | 0.01% | 1056 |
|
|
2020
Q4 | $616K | Sell |
29,095
-2,172
| -7% | -$46K | 0.01% | 758 |
|
|
2020
Q3 | $463K | Sell |
31,267
-2,094
| -6% | -$31K | 0.01% | 793 |
|
|
2020
Q2 | $491K | Sell |
33,361
-2,979
| -8% | -$43.8K | 0.01% | 788 |
|
|
2020
Q1 | $427K | Hold |
36,340
| – | – | 0.01% | 723 |
|
|
2019
Q4 | $854K | Buy |
+36,340
| New | +$854K | 0.02% | 623 |
|